Krisna SS - Search Results

1

The MNK1/2-eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer.

Guo Q, Bartish M, Gonçalves C, Huang F, Smith-Voudouris J, Krisna SS, Preston SEJ, Emond A, Li VZ, Duerr CU, Gui Y, Cleret-Buhot A, Thebault P, Lefrère H, Lenaerts L, Plourde D, Su J, Mindt BC, Hewgill SA, Cotechini T, Hindmarch CCT, Yang W, Khoury E, Zhan Y, Narykina V, Wei Y, Floris G, Basik M, Amant F, Quail DF, Lapointe R, Fritz JH, Del Rincon SV, Miller WH Jr. Guo Q, et al. Among authors: krisna ss. Cancer Res. 2021 Jul 15;81(14):3876-3889. doi: 10.1158/0008-5472.CAN-20-3143. Epub 2021 May 11. Cancer Res. 2021. PMID: 33975880

2

Optimized protocol for immunophenotyping of melanoma and tumor-bearing skin from mouse.

Krisna SS, Goncalves C, Gagnon N, Huang F, Plourde D, Miller WH Jr, Fritz JH, Del Rincon SV. Krisna SS, et al. STAR Protoc. 2021 Jul 2;2(3):100627. doi: 10.1016/j.xpro.2021.100627. eCollection 2021 Sep 17. STAR Protoc. 2021. PMID: 34258591 Free PMC article.

3

The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.

Mindt BC, Krisna SS, Duerr CU, Mancini M, Richer L, Vidal SM, Gerondakis S, Langlais D, Fritz JH. Mindt BC, et al. Among authors: krisna ss. Front Immunol. 2021 Nov 16;12:664218. doi: 10.3389/fimmu.2021.664218. eCollection 2021. Front Immunol. 2021. PMID: 34867937 Free PMC article.

4

Tongue carcinoma infrequently harbor common actionable genetic alterations.

Tan DS, Wang W, Leong HS, Sew PH, Lau DP, Chong FT, Krisna SS, Lim TK, Iyer NG. Tan DS, et al. Among authors: krisna ss. BMC Cancer. 2014 Sep 19;14:679. doi: 10.1186/1471-2407-14-679. BMC Cancer. 2014. PMID: 25234657 Free PMC article.

5

Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.

Ang SH, Haaland B, Acharyya S, Thu MM, Krisna SS, Hwang SG, Tan PH, Ng QS, Tan DS, Tai WM, Tan EH, Lim WT, Ang MK. Ang SH, et al. Among authors: krisna ss. Head Neck. 2015 Nov;37(11):1650-9. doi: 10.1002/hed.23803. Epub 2014 Aug 28. Head Neck. 2015. PMID: 24953865

6

Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer.

Tan DS, Haaland B, Gan JM, Tham SC, Sinha I, Tan EH, Lim KH, Takano A, Krisna SS, Thu MM, Liew HP, Ullrich A, Lim WT, Chua BT. Tan DS, et al. Among authors: krisna ss. Mol Cancer. 2014 Jan 24;13:13. doi: 10.1186/1476-4598-13-13. Mol Cancer. 2014. PMID: 24461128 Free PMC article.

7

Microfluidic enrichment for the single cell analysis of circulating tumor cells.

Yeo T, Tan SJ, Lim CL, Lau DP, Chua YW, Krisna SS, Iyer G, Tan GS, Lim TK, Tan DS, Lim WT, Lim CT. Yeo T, et al. Among authors: krisna ss. Sci Rep. 2016 Feb 29;6:22076. doi: 10.1038/srep22076. Sci Rep. 2016. PMID: 26924553 Free PMC article.

8

Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.

Khoo BL, Warkiani ME, Tan DS, Bhagat AA, Irwin D, Lau DP, Lim AS, Lim KH, Krisna SS, Lim WT, Yap YS, Lee SC, Soo RA, Han J, Lim CT. Khoo BL, et al. Among authors: krisna ss. PLoS One. 2014 Jul 7;9(7):e99409. doi: 10.1371/journal.pone.0099409. eCollection 2014. PLoS One. 2014. PMID: 24999991 Free PMC article.

9

Mutational Aberrations Detected in Mucinous Epithelial Ovarian Cancer of Asian Women.

Chay WY, Kwok LL, Tiong WN, Krisna SS, Lim KH, Iyer NG, Goh LK, Tan DS. Chay WY, et al. Among authors: krisna ss. Int J Gynecol Cancer. 2018 Mar;28(3):428-436. doi: 10.1097/IGC.0000000000001138. Int J Gynecol Cancer. 2018. PMID: 29465505

10

Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.

Prabhu SA, Moussa O, Gonçalves C, LaPierre JH, Chou H, Huang F, Richard VR, Ferruzo PYM, Guettler EM, Soria-Bretones I, Kirby L, Gagnon N, Su J, Silvester J, Krisna SS, Rose AAN, Sheppard KE, Cescon DW, Mallette FA, Zahedi RP, Borchers CH, Del Rincon SV, Miller WH. Prabhu SA, et al. Among authors: krisna ss. Mol Cancer Ther. 2023 Feb 1;22(2):192-204. doi: 10.1158/1535-7163.MCT-22-0092. Mol Cancer Ther. 2023. PMID: 36722142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page